Use cases — stage 05
Data Providers
Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
337 stories across 14 vendors
AlphaSense52
- 013M's healthcare-focused Global Strategy & Market Development team (per the featured exec, whose quote ties the work to "driving healthcare forward") uses AlphaSense to speed up research synthesis and become more responsive to executives
- 02A TCR-based immunotherapy biotech uses AlphaSense as a "one-stop-shop" to accelerate market research within budget constraints
- 03A healthcare-intelligence firm chose AlphaSense for faster, money-saving market and company intelligence
- 04"A BioPharma Insights Company" — Uses AlphaSense to analyze drug projections and access expert interviews for faster, more informed investment decisions
- 05Biotech investment firm — A biotech-focused investment firm specializing in fundamental research uses AlphaSense as a one-stop shop for research content
- 06The ~100-year-old global integrated healthcare services and products company uses AlphaSense to augment its research
- 07The bank's investment-banking/wealth-management team accelerates deal research by 50% with AlphaSense; page is dual-tagged "Financial Services" and "Life Sciences & Healthcare" by AlphaSense (likely reflecting healthcare-sector deal coverage, not that Emirates NBD itself is a life-sciences company
- 08The healthcare group cuts hours from its investor-relations workflow, monitoring market sentiment and keeping messaging consistent across teams
- 09The biotech uses AlphaSense to speed up competitive intelligence by 120x and make faster, data-driven R&D decisions
- 10Merz Aesthetics' Director of Market Intelligence (a "one-woman program") uses AlphaSense's AI search to hit tight earnings-recap deadlines
- 11A competitive-intelligence expert (currently Director of CI at the gene-editing biotech Precision BioSciences, previously at other pharma companies) saves tens of thousands of dollars a year and cuts research time from 24 hours to 30 minutes using AlphaSense
- 12The biopharma royalty company drives efficiency gains, streamlines workflows, and improves knowledge sharing with AlphaSense (30% less time on daily research; 3-4 analysts doing the work of 100+
- 13The competitive-intelligence arm of Cambridge Healthcare Research (serving pharma clients across oncology, rare disease, infectious disease) eliminates research bottlenecks and scales AlphaSense access org-wide
- 14The Italian pharmaceutical group accelerates research with AlphaSense
- 15The women's-health pharma company (fertility, contraception, menopause, uterine health, osteoporosis; 50+ countries) uses AlphaSense to fuel global growth and expansion into new territories
- 16Aerospace company (CI leader) — Uses AlphaSense (WSI) to uncover in-depth research and strategic insights; drives better client service and technology decisions
- 17Saw a 300% increase in team platform engagement after switching to AlphaSense
- 18"a highly regarded asset manager" — A private equity firm known for superior returns saves time on due diligence with AlphaSense
- 19Sell-side equity research analyst — Automates an "onerous" equity research process, likened to how Google automated the library
- 20The consulting/accounting firm cuts research time from hours to minutes, scaling meeting prep and client insight delivery with AlphaSense
- 21Reduces research costs and accelerates decision-making with AlphaSense's AI market-intelligence platform
- 22Saves hundreds of hours gaining access to the right intelligence via AlphaSense
- 23The CPG company's competitive-intelligence analyst tracks competitors and market trends in real time, saving hours of manual research daily
- 24The Director of Competitive Intelligence increases confidence in, and speed of, research — a "double win"
- 25$50B AUM fund (fund of funds) — Sources, underwrites, and structures public/private investments; AI increases efficiency
- 26The Toronto strategy-consulting firm delivers faster client research and market insight with AlphaSense
- 27"global science and technology leader" — A diversified ~70-country company spanning healthcare, industrial, consumer, and electronics escapes "information graveyards" (scattered folders/drives) with AI-driven market intelligence; touches healthcare but is not primarily a pharma/life-sciences company, so not tagged pharma here
- 28Global manufacturing leader — Overcomes information overload and fragmented data sources to accelerate innovation with AI
- 29Global tech company — Moves from alert fatigue to strategic precision, fixing fragmented market monitoring and low-quality data
- 30Private equity leader — Fixes slow, manual market-research processes, inconsistent data, and misinformation risk with AI
- 31Deep-dives into new investment territory (solar) using expert transcripts and targeted company analysis
- 32Cuts research time by 50%, never missing investment opportunities across portfolio companies
- 33Semiconductor leader — A semiconductor giant with 22,000 employees uses AI to monitor competitors and assess investments faster
- 34Large midstream energy company — Tracks industry shifts and accesses broker research to navigate the energy transition
- 35Partners with AlphaSense to transform corporate-strategy workflows, compound knowledge, and drive confident executive decisions
- 36Cuts research time in half finding market intelligence, patents, and industry trends
- 37Portfolio managers save 4-5 hours a week and gain investment confidence via AlphaSense
- 38Unifies investor, corporate, and market intelligence using AlphaSense's Deep Research, Generative Grid, and dashboards
- 39Finds investment insights faster via expert transcripts, smart search, and filtering
- 40Sell-side analyst Howard Mason streamlines coverage of securities and macro-trend content with AlphaSense
- 41An analyst saves 25% of time during earnings season via comprehensive earnings analysis
- 42The competitive-intelligence team tracks competitors and makes strategic decisions faster with expert insights
- 43Achieves sustainability goals with AlphaSense's research platform
- 44Transforms its market-strategy team into a "forge" of shared insight via AlphaSense's AI-powered research infrastructure
- 45Achieves a 4x productivity increase (5 to ~20 reports in 48 hours) with AI-driven market intelligence
- 46Simplifies comprehensive competitive research central to its digital-transformation mission
- 47Uses AlphaSense's agentic AI to revolutionize its market-intelligence process
- 48Cuts research costs and gains deeper market insight, replacing expensive expert networks with AlphaSense Expert Insights
- 49Unlocks confident decision-making via AlphaSense's document search
- 50The Market & Competitive Insights team reduces search time, saves money, and generates new revenue-relevant insight
- 51Uses AlphaSense's generative AI search to track competitors, analyze market trends, and lead sustainable-mining initiatives
- 52A Singapore public/private equity firm transforms its investment-research process, driving speed and conviction with AlphaSense
Optum46
- 01Health system partnership drove a stronger financial future through RCM services
- 02Second case study on revolutionizing its cardiology program with Optum
- 03Contracted clinician describes his experience joining the Optum Network
- 04Physician's transition to value-based care with Optum Network support
- 05How Optum Network support reduced his practice workload
- 06Digital integration case study to reduce administrative burden in assessment programs
- 07CDI/coding technology increased monthly case review average by 22%
- 08Second story: AI helps the health system manage costs and focus on patients, not paperwork
- 09Improved CDI efficiency using Optum technology
- 10Used Optum Market Advantage data to drive health system growth
- 11New billing system reduced bad debt and increased cash
- 12Maintained financial stability during COVID-19 with Optum RCM
- 13Automated online scheduling for COVID-19 vaccinations
- 14Mobile medical clinic bringing care to underserved Nevada communities
- 15Digital payer-channel scheduling increased volumes and cut no-shows
- 16Improved efficiency through an intelligent imaging workflow
- 17RCM services helped the lab navigate difficult reimbursement waters
- 18Boosted EMS billing collections by 40%
- 19Analytics dashboard improved substance-use-disorder program management
- 20New data/analytics approach to Medicaid program management and fraud recovery
- 21Improved RCM and profitability for physician practices
- 22Behavioral health network expanded digital-first patient access via self-scheduling
- 23Simplified mental health access through online/digital scheduling
- 24Optum Serve supports military entrance processing operations
- 25Cooperative purchasing organization streamlines state procurement with Optum
- 26HouseCalls in-home assessments linked to fewer ED visits and hospital stays
- 27Emotional wellbeing/EAP support tailored to firefighters' needs
- 28Corporate health engagement solution to boost employee fitness and wellbeing
- 29Closed care gaps through annual in-home assessments (7.69:1 ROI
- 30Third case study: IT performance services partnership described as "a model IT" relationship
- 31Predictive analytics (Optum One) for population health/chronic disease management
- 32Intelligent Perioperative Suite increased patient throughput and satisfaction
- 33Structured cardiovascular reporting cut unsigned charges within 5 days by 79%
- 34InterQual solutions transformed utilization/case management
- 35Impact Pro drove $1.1M in benefits and productivity gains
- 36Journey to a four-star CMS Star Rating
- 37Tailored financial/emotional wellbeing support eased employee stress
- 38Optum Advocacy solution drove measurable results
- 39Clinical collaboration ensured timely access to HIV PEP medications
- 40Robotic process automation saved 9,465 hours and $950,000 over 5 years
- 41Transition to cloud-native PACS/enterprise imaging
- 42Personal story illustrating women's health support beyond reproductive care
- 43Infusion nurse's quick action credited with saving a patient's life
- 44Case study on investing in employees' financial wellbeing/success
- 45Emotional wellbeing solutions deployed for health care workers
- 46"From transformation to triumph" turnaround case study
Definitive Healthcare45
- 01Powered their HubSpot CRM with Definitive Healthcare data to reduce costs and sharpen go-to-market strategy
- 02Enabled 35–45% more effective budget management
- 03Identified the right markets, driving focused and sustainable growth
- 04Closed 10 deals totaling over $1.3M in 18 months
- 05Optimized sales strategy with better intelligence on health-system relationships
- 06Reduced lead-generation costs using Definitive Healthcare intelligence
- 07Gained ROI through significant weekly time savings
- 08Ramped up business development capabilities
- 09Refined targeting to efficiently pinpoint organizations running cancer clinical trials
- 10Identified new contacts, new markets, and new opportunities
- 11Increased sales-team efficiency with unique customer insights
- 12Closed more deals with healthcare commercial intelligence
- 13Achieving ROI with clinical propensity model targeting
- 14Increasing appointments with targeted service-line marketing campaigns
- 15Understanding the competitive landscape with healthcare commercial intelligence
- 16Informing clinical care programs and partnerships with data and analytics
- 17Identifying relevant KOLs on a global scale
- 18Quickly finding global prospects with healthcare commercial intelligence
- 19Enabling a brand to move from later- to earlier line of therapy
- 20Optimizing promotional planning while reducing consultant dependencies
- 21Optimizing marketing and sales investments across brands and regions
- 22Expanding the HCP target list for a new drug treating a rare disease in children
- 23Accelerating Phase III clinical trial enrollment
- 24Predicting patients with an ultra-rare disease for treatment launch planning
- 25Increased medical affairs engagement by 40% engaging the right rare-disease KOLs
- 26Attracted more healthcare market share by leveraging healthcare commercial intelligence
- 27Year-over-year increase in reorder revenue and procedure volume
- 28Uncovered 15 net-new physicians treating a rare disease
- 29$7M return in the first year through market expansion
- 30Understanding competitive landscape
- 3130% increase in accuracy of market opportunity analysis, driving marketing-campaign success
- 32140 additional highly qualified sales leads identified
- 33Increased stroke-estimate precision to ~90% at key hospitals via elevated sales segmentation/messaging
- 34Converted 12 prospects into clients within 5 months, growing revenue and shortening the sales cycle
- 35900 KOLs uncovered, driving commercial launch success
- 36Building a reliable marketing contact database
- 37Powering commercial teams with a robust CRM
- 38Calculating total addressable market ~7x faster
- 39Driving market expansion by influencing patient referral leakage
- 40Generating new provider referral streams
- 41Powered product launches with claims and affiliations data, used across 52 additional client projects in the following year
- 42Recaptured market share and accelerated revenue growth
- 43Accelerated go-to-market for a new device
- 44Sized and segmented the market for an innovative cancer-treatment device, addressing misdiagnosis/treatment-delay challenges — (referenced via site search; specific URL not directly captured
- 45Featured multi-customer panel video case study
Norstella40
- 01MMIT used NorstellaLinQ to merge unstructured EMR data with structured data to detect disease screening patterns and drive commercialization strategy
- 02MMIT used NorstellaLinQ real-world data to narrow a target patient population and improve physician targeting
- 03MMIT used NorstellaLinQ to give a clearer real-time picture of high-risk patients and the physicians treating them
- 04Panalgo linked unstructured EMR data (via NorstellaLinQ) with closed claims data for an HEOR study on knee arthroplasty, delivering years of longitudinal data in 8 weeks
- 05"NorstellaLinQ: Better together — Getting the full patient picture" use case
- 06CRO used Citeline to validate site/investigator hypotheses for a Phase III oncology "trial rescue," uncovering protocol constraints and competitive-intensity insights
- 07Patient advisory board reviewed Citeline Connect's IRB-approved outreach materials and Clinical Trial Portfolio Websites to improve trial recruitment
- 08"Global Patient Insights" use case: optimized investigator selection and diversity goals for a Phase II mRNA solid-tumor cancer trial
- 09"A Patient-centric Approach to Clinical Trial Site Selection" — Citeline datasets used to match site/investigator selection to IgA nephropathy patient epidemiology
- 10Referenced via search only ("Case Study - Patient Input in Trial Recruitment") — same as Smart Patients entry above (duplicate title indexed differently
- 11Screened 4,700+ oncology assets with a bespoke prioritization model to select 5 in-licensing candidates
- 12Evaluate ran partner search/outreach for two early-stage oncology assets, achieving a 30% response rate and interest from 3 major pharma companies
- 13Evaluate built a 24/7 competitive-intelligence monitoring program shifting the client from reactive to proactive CI
- 14J+D Forecasting overhauled oncology forecasting from fragmented finance-led models to a scalable framework ahead of a Phase III launch
- 15Custom virtual forecasting-training program standardized practices across regional teams
- 16"Case Study Archives" index page exists (evaluate.com/category/case-study/) but its full entry grid could not be enumerated (JS-rendered); the 5 entries above are the ones found, more may exist
- 17Consulting firm used MMIT Analytics and FormTrak to help a pharma client communicate product coverage info to providers
- 18Used MMIT data/insights to achieve 95% payer coverage for a rare disease therapy at launch
- 19Used MMIT's Strategic Launch Report/analogs to build a competitor risk-mitigation strategy
- 20Tracked real-time market access data and identified high-value HCPs for targeted outreach via MMIT's core solutions
- 21Merged unstructured EMR + structured data via NorstellaLinQ to detect disease-screening patterns
- 22How MMIT's Contract Validation solution streamlines rebate/contract-position validation against formularies
- 23Used MMIT real-world data to uncover hidden market-access opportunities
- 24Business-development firm used MMIT's Reach + Directory of Health Plans data to generate medtech leads in the payer space and hit KPIs
- 25Used IDN Formulary Insights to drive utilization gains after favorable-but-underused formulary placement
- 26Mapped a one-year post-launch patient journey by combining open/closed claims with transactional records via a token engine
- 27"Simplify Coverage Checks with BPG" — incorporated BIN/PCN/Group fields into its platform for seamless benefit verification (title truncated in search index; URL not directly confirmed
- 28"Ensure Accurate Reimbursement with MMIT's..." — developed communications about an infusion therapy's new NDC/J-codes to reduce claim denials (title truncated; URL not directly confirmed
- 29"Improving Launch Coverage With Insights" — partnered with MMIT to understand payer perspectives and refine brand messaging (URL not directly confirmed
- 30"From Guesswork to Clarity: Gaining..." — used MMIT Analytics and Searchlight to obtain detailed payer landscape info by geography (title truncated; URL not directly confirmed
- 31ReimbursementCodes case: saved $250K+/year by automating claims review
- 32Research team used Panalgo's IHD Analytics platform to evaluate comorbidities among vitiligo patients from a large U.S. commercial claims database
- 33Nonprofit combined its registry data with external data sources via Panalgo to unlock novel Type 1 diabetes research
- 34Generated HEOR data (via NorstellaLinQ) on cemented vs. uncemented knee arthroplasty, getting years of longitudinal data in 8 weeks
- 35Achieved major cost savings and productivity gains on a clinical-trial-diversity analytics project without hiring/outsourcing
- 36IHD Data Science module accelerated an analytics project from months to weeks
- 37Used unstructured EMR data to expand a rare-disease patient cohort by 1,500% after ICD-10 codes missed patients
- 38Hosted an internal "datathon" using Panalgo's IHD Data Science module to build staff RWD/AI/ML literacy
- 39Replicated a 14-month dissertation analysis (opioid use disorder) in 1 week using Panalgo's self-service platform
- 40Completed analyses informing an observational study design in 6 weeks instead of months
GlobalData25
- 01Used GlobalData's analytical modeling to evaluate expansion across 150+ markets and launched a new non-beer brand in Europe via a strategic partnership
- 02Used GlobalData's combined agribusiness + consumer/retail intelligence to track EU sugar volume consumption by country/category since 2015 for sales, marketing and strategic planning
- 03Same EU sugar-consumption dataset engagement as above, published under a second URL
- 04Commissioned a market-sizing study across liquid food & beverage categories and used GlobalData's model to rank market-entry options, launching a non-beer beverage brand in Europe with a partner
- 05Engaged GlobalData to analyze competitor activity across consumer "demand spaces" to guide where to invest strategically
- 06Commissioned a consumer-spending forecast tied to Taylor Swift's 2024 Eras Tour (survey of 1,500 shoppers), then published the report and ran a themed promo campaign
- 07Used GlobalData's Packaging Intelligence Centre for annual/quarterly dairy- and soft-drinks packaging data across 100+ countries for planning
- 08Commissioned a GlobalData Agribusiness economic-impact analysis on oilseeds/grains/pulses processing's contribution to Canada's economy — (note: title mismatches content — page content is the Canadian farmers' association study, not an apparel printer
- 09Engaged GlobalData to evaluate a small-molecule vs. antibody therapeutic for CMV-infection prevention across 7 major markets (clinical pathway mapping, KOL interviews, forecasting
- 10Used GlobalData's primary/secondary research to build a prospect list and operator briefing on polyester printing businesses in target European markets
- 11Integrated GlobalData's APIs/data feeds into an internal portal to give account teams real-time company/industry/competitor insight
- 12Commissioned market research on the global LPG & ethylene shipping market (key players, growth to 2030) to inform vessel-sizing and expansion decisions
- 13Used GlobalData's financial-health ratings on general insurers to monitor carrier stability and meet regulatory audit requirements
- 14Commissioned a South Asia market study (sizing, competition, soil conditions, regulation) to build a market-entry strategy
- 15Used GlobalData's proprietary Mining Equipment Predictor Model to size demand for a new telescopic tyre-handler attachment
- 16Trend report: 4 food & beverage growth opportunities for 2025 (personalized women's health, sustainability, health-longevity, flavor expansion
- 17Trend report: how cannabis users' consumption behavior differs from other consumers across 5 markets, and the implications for CPG brand strategy
- 18Trend report: 5 foodservice trends for 2025 (multi-channel commerce, promo deals, plant-based, social media, supply-chain transparency); illustrates with unnamed example Pasta Evangelists
- 19Used GlobalData's platform (incl. Malaysia ICT Tracker) for 5+ years for strategic planning, market forecasting and competitive benchmarking in ICT
- 20Used GlobalData's AI Hub (Ava AI Research Analyst) to cut research time from days to hours and improve confidence in insights
- 21Analyst Relations team used GlobalData's AI Hub to streamline research synthesis and democratize market-intelligence access org-wide
- 22Trend/whitepaper: the $417bn smart-cities opportunity and the IoT stack organizations need to capitalize on it
- 23Trend report: MEA trade-corridor infrastructure reshaping construction value (59% of MENA transport/logistics projects concentrated in 2 countries
- 24Trend report: data-center technology convergence amid a $2.5tn global project pipeline and AI-workload challenges
- 25Trend report ("The Race for Speed to Power"): energy-sector dynamics incl. LNG demand forecasts and interconnected energy decisions
Clarivate23
- 01Evolved its commercial, marketing and customer-engagement strategy using Clarivate real-world data and analytics
- 02Used Clarivate/Cortellis IP and business support to advance a blood test for early ovarian cancer detection toward commercialization
- 03Used Clarivate asset/technology and IP valuation expertise to make informed investment decisions in breakthrough biotech and science innovations
- 04Partnered with Clarivate Regulatory Intelligence Tracking Application (companion to Cortellis Regulatory Intelligence) to transform and streamline regulatory workflow
- 05Used a Clarivate patient-journey-mapping framework to integrate patient centricity into its mature/mid-lifecycle brand strategy in Asia Pacific, improving patient outcomes and brand awareness
- 06Used Clarivate's DialogML (with Dialog and Drug Safety Triager) to apply AI/NLP to detect Individual Case Safety Reports (ICSRs) in scientific literature more efficiently for pharmacovigilance
- 07Used Clarivate data to gain detailed insight into the UK rare-disease research landscape and inform future policymaking
- 08Used Cortellis Deals Intelligence together with Cortellis Competitive Intelligence to secure the best price/terms while out-licensing its abuse/overdose-resistant prodrug technology
- 09Used a Clarivate knowledge-graph/drug-repurposing framework spanning Cortellis Drug Discovery Intelligence to identify existing drugs usable as medical countermeasures for chemical-agent exposure
- 10Researchers used Clarivate pathway-analysis tools to let biologists self-serve omics data analysis (freeing up the bioinformatics team) to make go/no-go drug-development decisions
- 11Combined multiple real-world data sources via Clarivate to compare internal sales data against estimated device volumes and sharpen commercial targeting
- 12Used Cortellis granular sites data plus incidence/prevalence and U.S. claims data, and Clarivate Consulting Services, to select trial sites/investigators for a late-stage rare-disease trial
- 13Worked with Clarivate regional regulatory experts and regulatory intelligence solutions to streamline monitoring/distribution of fast-moving global regulatory requirements
- 14Used Clarivate network/biological-mechanism tools to systematically identify and prioritize alternative indications for a promising drug asset in the APAC market
- 15Used a Clarivate knowledge-graph architecture (incl. MetaBase, Cortellis Drug Discovery Intelligence) to integrate clinical multi-omics data with public datasets and understand drug-response mechanisms
- 16Used Clarivate systems-biology/network tools to validate the mechanism of action of a lead kinase inhibitor and identify resistance biomarkers for patient stratification
- 17Ran a compliant digital messaging campaign (GPs and pharmacists) to escalate under-treated severe-asthma patients onto a new product, reportedly driving 350k fewer asthma attacks
- 18Ran an EHR-embedded digital messaging campaign to identify at-risk COPD patients and escalate them to guideline-recommended triple therapy, reportedly driving a 31% increase in triple-therapy prescriptions
- 19Ran a 19-month clinical messaging campaign to drive prescribing of the newly launched product, reportedly achieving an 89% increase in prescriptions
- 20CDK inhibitor class safety) — Illustrates how OFF-X translational safety intelligence can assess whether ocular toxicity is a class effect of CDK inhibitors, using public clinical-hold disclosures as the example
- 21Adverse-event mechanism ID) — Illustrates how the OFF-X Translatability Dashboard can identify plausible mechanisms behind an anaphylactoid reaction seen in a preclinical rat safety study
- 22Lisaftoclax patient-safety profiling) — Illustrates how OFF-X Translational Safety Intelligence uncovered an unexpected patient-condition-specific safety association for the Bcl-2 inhibitor lisaftoclax to inform smarter clinical-trial design
- 23Video customer story (Vidyard modal, not a standalone page) describing a partnership using Clarivate data and technology to help reduce the U.S. child-suicide rate; tagged under the "Life Sciences & Healthcare" segment on the general customer-stories hub
HealthVerity23
- 01Partnered to improve rare-disease campaign targeting using Symphony Health custom audience data and an Audience Quality Index
- 02Used RWE to sharpen launch strategy and prescriber/patient targeting for an oral TYK2 inhibitor in psoriasis
- 03Achieved 26.9x targeting precision in a rare kidney disease campaign via HealthVerity Audiences
- 04Supplemented claims with oncology lab results to narrow 75,395 metastatic breast cancer patients to 1,188 subtype-confirmed patients
- 05Used deeper clinical context via HealthVerity Audiences to more precisely target chronic liver disease patients for a specialty therapy
- 06Used observed clinical signals instead of modeled assumptions to reach a rare hematologic disease patient population
- 07Used HealthVerity eXOs to answer early evidence questions and validate research direction in under an hour
- 08Analyzed GLP-1 persistence and adherence over two years across ~3.9M semaglutide patients
- 09Ran six effectiveness/comparative studies of an anti-seizure medication against competing therapies
- 10Validated whether its target audience had heart failure to get real-time campaign effectiveness insights
- 11Used real-time media attribution to optimize marketing campaigns while staying HIPAA-compliant
- 12Analyzed linked claims/EHR data on high-risk non-muscle-invasive bladder cancer patients who failed BCG therapy, revealing a care gap
- 13Ran a retrospective study of 3,095 HIV/HBV-coinfected adults to find a treatment protecting against liver disease
- 14Evaluated HIV testing patterns among ~983 long-acting injectable cabotegravir (CAB-LA) PrEP users
- 15Demonstrated secure linkage of sensitive federal datasets across two agencies without exposing PII
- 16Found cenobamate monotherapy cut inpatient days and ER visits among 299 epilepsy patients
- 17Studied disparities in OUD treatment outcomes (buprenorphine vs. naltrexone) using Marketplace claims data
- 18Compared virtual vs. in-person physical therapy costs/utilization using closed claims from HealthVerity Marketplace
- 19Ran the SEPRA (SEmaglutide randomized PRAgmatic) trial, using Identity Manager to link 1,278 trial participants to real-world claims (87% tokenized
- 20Combined structured claims with unstructured clinical notes to identify ~287K long COVID patients, 19% more than codes alone
- 21Built a regional analytics platform tracking severe obstetric complications and heart disease by ZIP3 to target local interventions
- 22Uses HealthVerity's data repository to support drug approval processes and AI-driven regulatory decision-making
- 23Partnered via the eXOs platform to give researchers no-code AI analytics tools for RWE research
Merative17
- 01Advances research with diverse, longitudinal MarketScan real-world data
- 02Cloud-based real-world data access via MarketScan to empower researchers, shared as part of Merative's RWD-in-the-cloud journey series
- 03Increased sample size and strengthened insights using longitudinal MarketScan RWD to study medication/pregnancy-outcome associations
- 04Examined variations in elective surgery prices across the US using MarketScan data
- 05Transformed drug-shortage management using OrbitalRX
- 06Gained efficiency and control over clinical trials
- 07Served its expanding clientele with a modular clinical development solution
- 08Accelerated processes across the clinical development life cycle
- 09Reduced overhead, costs, and time by improving the clinical trial process
- 10Case study on clinical development solution adoption
- 11Empowered medical coders with faster, more precise medical coding
- 12The right technology and team helped this CRO focus on client success
- 13Life-saving treatments reach patients faster
- 14Zelta customer-satisfaction case study
- 15Featured Zelta case study
- 16Merge PACS medical-imaging case study
- 17Used Merative Health Insights to measure the impact of employee health on productivity and absenteeism
Datavant14
- 01Ran a 36-week Phase IV study (175 patients, 40 sites) using trial tokenization to link to real-world data, extending effectiveness/safety analysis of a new focal seizure treatment
- 02Built a model (with Datavant matching/linking) to identify hereditary ATTR amyloidosis patients, identifying 60+ new cases
- 03Used Datavant's identity resolution technology to narrow duplicate patient counts by 96 million (22%), producing a higher-quality, more comprehensive real-world dataset
- 04Peer-reviewed studies using patient-level health data connected by Datavant technology to study intervention/policy effects on outcomes
- 05Partnered with Datavant on a flexible, scalable medical coding model to overcome staffing challenges and strengthen compliance
- 06Accessed curated AAO IRIS Registry data to understand disease burden, clinical outcomes, comorbidities, and cost/utilization for rare eye disease patients
- 07Used Datavant Switchboard to connect specialty pharmacy and patient-hub data to real-world data, addressing infusion-therapy treatment discontinuation and improving patient adherence
- 08Transformed risk adjustment and care coordination using Datavant's Clinical Data Platform for real-time, structured clinical data acquisition
- 09Implemented a digital solution for provider-payer collaboration on managed care audit processing
- 10Used 100M+ linked EHR records for near-real-time COVID-19 analysis to guide healthcare policy
- 11Linked oncology diagnostic lab data to assess a blood test's effectiveness in supporting immunotherapy treatment selection for lung cancer
- 12Overview of how Datavant powers external control arms using real-world data, illustrated with an oncology case
- 13Phase III COVID-19 vaccine study using trial tokenization to link to RWD, tracking long-term effectiveness/safety and infection rates beyond the trial period
- 14Connected specialty drug data via Datavant for better physician targeting after a rare-condition drug's sales lagged due to difficulty finding eligible patients
Flatiron Health14
- 01Used Flatiron's Enhanced Data Mart for real-world/external-control analysis supporting Canadian HTA reimbursement approval of a BRAF V600E–targeted NSCLC treatment
- 02Used Flatiron's Clinical Genomics Database (with Foundation Medicine) for a natural-history study of 743 KRAS G12C patients supporting Lumakras FDA approval
- 03Used Flatiron's Spotlight database for benchmark/indirect-comparison analyses supporting the mobocertinib (Exkivity, EGFR Exon20ins) regulatory/HTA submission
- 04Used de-identified Flatiron EHR data to study unmet need in mantle cell lymphoma post-cBTKi therapy, supporting FDA accelerated approval of pirtobrutinib
- 05Used Flatiron real-world data to compare overall survival of niraparib maintenance therapy vs. active surveillance in recurrent ovarian cancer
- 06Used EHR-derived RWD to identify low-LVEF metastatic breast cancer patients on Kadcyla (T-DM1), fulfilling a post-approval regulatory commitment and securing label updates in the US/EU/Canada
- 07Partnered with Flatiron to design a prospective clinico-genomic study using routine-care data for advanced lung cancer patients
- 08Adopted Flatiron Assist clinical decision support, reaching 84% clinician adoption and high preferred-regimen use within 14 months
- 09Adopted Flatiron Assist, achieving high concordance with NCCN Guidelines and faster adoption of novel therapies
- 10Replaced paper research logs with electronic adverse-event documentation in OncoEMR, cutting investigator sign-off time to ~5 hours
- 11Used Flatiron's automated 505(b)(2) ingredient drug-substitution feature in OncoEMR to streamline formulary management
- 12Praised Flatiron Assist for quick, intuitive point-of-care treatment navigation
- 13Praised OncoEMR's usability
- 14Natural-history study comparing early-onset gastric/colorectal cancer prevalence in Japan vs. the US using EHR-derived RWD
TriNetX14
- 01Used TriNetX to streamline clinical trial site identification/outreach, replacing manual/paper processes and raising site acceptance rates from 17% to 32%
- 02Partnered on a technology-driven approach to trial feasibility assessment and site selection, expanding recruitment beyond their traditional site network
- 03Used TriNetX RWD and predictive analytics to improve clinical trial enrollment for systemic lupus erythematosus (SLE) research
- 04Accessed data on ~200,000 burn patients to rapidly analyze rare burn conditions, uncovering mortality-rate and drug-related findings
- 05Joined the TriNetX network for access to 68M+ de-identified patient records across 49 organizations, expanding research and publication output
- 06Completed analytics work in 3 months that previously took 3–4 years, streamlining clinical-trial participant identification
- 07Used TriNetX data to demonstrate feasibility and win a grant studying COVID-19/thrombosis risk in sickle cell disease patients
- 08Increased incoming clinical trial leads 20–30x and published a hydroxychloroquine/COVID-19 outcomes study
- 09Conducted retrospective studies on the mental-health and neurological impacts of COVID-19, publishing in Lancet Psychiatry and PLOS Medicine
- 10Joined TriNetX for trial-opportunity access and RWD from 40+ organizations, generating 200+ trial opportunities and 19 publications in one year
- 11Implemented the TriNetX LIVE platform to automate patient recruitment, replacing manual feasibility estimation with data-driven assessment
- 12Embedded real-world data and AI earlier in trial planning to accelerate study-design decisions
- 13Examines why clinical AI models require local/regional validation to perform reliably across geographies
- 14Applied AI-driven, human-in-the-loop extraction from unstructured clinical notes to recover smoking-status data, improving data completeness and trial-feasibility/AI performance
Symphony Health10
- 01Used Symphony Health's Integrated Dataverse (IDV®) claims data + machine learning to identify undiagnosed lung cancer patients pre-diagnosis, for targeted diagnostic-tool deployment
- 02Used Symphony Health's IDV® to build a longitudinal psoriasis patient/prescriber cohort guiding launch strategy for an oral TYK2 inhibitor
- 03Symphony Health RWD analysis showing access barriers to branded CGRP migraine therapies disproportionately affect marginalized populations
- 04Symphony Health conducted a line-of-therapy analysis on pulmonary arterial hypertension patients to inform commercialisation strategy
- 05Symphony Health data powered privacy-safe, cookie-free digital ad targeting: 41% greater reach, 50% lower cost-per-diagnosed-patient
- 06Symphony Health + HealthWise Data used ML on integrated claims/environmental data to quantify how social determinants of health affect Type 2 diabetes treatment persistence
- 07Symphony Health evaluated whether a glucose-tracking wellness app could lower A1c levels and costs for Type 2 diabetes patients, to support payer adoption
- 08Symphony Health's proprietary audience model outperformed rival data partners in compliantly reaching rare (lung) disease patients for an unbranded education campaign
- 09Symphony Health measured a cardiovascular hospital-based point-of-care marketing campaign, showing statistically significant patient conversion lifts
- 10Symphony Health built a privacy-compliant, DMA-level/ML measurement approach for a social campaign, hitting 90% of standard-method accuracy under stricter privacy rules
Komodo Health9
- 01Collaborated with Komodo to modernize healthcare quality measurement using real-world data and healthcare-native AI
- 02Scaled an AI-powered intelligence platform enterprise-wide, cutting reporting cycles from months to hours
- 03Used real-world patient data to identify gaps in prostate cancer screening and care delivery
- 04Testimonial on Komodo's platform value
- 05Testimonial on Komodo's platform value
- 06Testimonial on Komodo's platform value
- 07Testimonial on Komodo's platform value
- 08"Iris Commercial Case Study" — A mid-size pharmaceutical company launching a rare-condition therapeutic used Komodo's Iris solution/Healthcare Map to grow targeted HCPs ~3x (539 → 1,414) and raised full-year financial guidance 44–60%
- 09Payer case study — A payer relying on siloed datasets joined its own data with Komodo's Healthcare Map to analyze full patient journeys, understand disease-prevalence trends by geography, target engagement, and cut downstream healthcare costs
Truveta5
- 01Compared its EKOS Endovascular System to Inari Medical's FlowTriever for pulmonary embolism treatment using Truveta Data, finding a higher bleeding risk with the competitor device; the "REAL-PE" study was published and presented within 5 months, versus the years/millions an RCT would have required
- 02Used Truveta Data to build the TREAT-AHF heart-failure registry (~165,000 acute decompensated heart failure patient journeys, ~3x the ADHERE registry), validating its decongestion device and optimizing clinical trial design/enrollment predictions
- 03Used Truveta Data to compare hemodialysis catheter designs across multiple health systems, evaluating infection risks and usage trends to guide product safety and development
- 04Analyzed real-world incidence and prevalence of arrhythmias among epilepsy patients to investigate potential cardiac risks associated with anti-seizure medications
- 05Partnered with Truveta (via Truveta Live Link) to securely link its continuous glucose monitoring (CGM) data with longitudinal EHR records for 200,000+ patients, enabling research into kidney disease progression, risk stratification, and real-world CGM therapy effectiveness